12-hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor

Journal of Experimental Medicine

Volumn 211, Issue 6, 2014, Pages 1063-1078

  Liu, Min ^a,b   Saeki, Kazuko ^a,b   Matsunobu, Takehiko ^b   Okuno, Toshiaki ^a,b   Koga, Tomoaki ^a,b   Sugimoto, Yukihiko ^c   Yokoyama, Chieko ^d   Nakamizo, Satoshi ^e   Kabashima, Kenji ^e   Narumiya, Shuh ^e   Shimizu, Takao ^f   Yokomizo, Takehiko ^a,b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GELATINASE B; HEPTADECA 5,8,10 TRIEN 12 OLOIC ACID; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR TYPE 2; LEUKOTRIENE RECEPTOR STIMULATING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL ASSAY; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; EPITHELIZATION; IN VITRO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCH BIOPSY; REDUCTION; SCRATCH ASSAY; SKIN INJURY; WILD TYPE; WOUND CLOSURE; WOUND FLUID;

ANIMALS; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FATTY ACIDS, UNSATURATED; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-1BETA; KERATINOCYTES; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, LEUKOTRIENE B4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 84901776364     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20132063     Document Type: Article

References (63)

1. Arita, M., M. Yoshida, S. Hong, E. Tjonahen, J.N. Glickman, N.A. Petasis, R.S. Blumberg, and C.N. Serhan. 2005. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA. 102:7671-7676. http://dx.doi.org/10.1073/pnas.0409271102.
2. Awtry, E.H., and J. Loscalzo. 2000. Aspirin. Circulation. 101:1206-1218. http://dx.doi.org/10.1161/01.CIR.101.10.1206.
3. Baum, C.L., and C.J. Arpey. 2005. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol. Surg. 31:674-686.
4. Borzini, P., and L. Mazzucco. 2005. Platelet gels and releasates. Curr. Opin. Hematol. 12:473-479. http://dx.doi.org/10.1097/01.moh.0000177831.70657.e8.
5. Brem, H., and M. Tomic-Canic. 2007. Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest. 117:1219-1222. http://dx.doi.org/ 10.1172/JCI32169.
6. Chan, A.T., S. Ogino, and C.S. Fuchs. 2007. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl. J. Med. 356:2131-2142. http://dx.doi.org/10.1056/NEJMoa067208.
7. Chiang, N., M. Arita, and C.N. Serhan. 2005. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot. Essent. Fatty Acids. 73:163-177. http://dx.doi.org/10.1016/j.plefa.2005.05.003.
8. Cho, K.J., J.M. Seo, Y. Shin, M.H. Yoo, C.S. Park, S.H. Lee, Y.S. Chang, S.H. Cho, and J.H. Kim. 2010. Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor. Am. J. Respir. Cell Mol. Biol. 42:294-303. http://dx.doi.org/10.1165/rcmb.2008-0445OC.
9. Clària, J., and C.N. Serhan. 1995. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA. 92:9475-9479. http://dx.doi.org/10.1073/ pnas.92.21.9475.
10. Cogswell, J.P., M.M. Godlevski, G.B. Wisely, W.C. Clay, L.M. Leesnitzer, J.P. Ways, and J.G. Gray. 1994. NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J. Immunol. 153:712-723.
11. Coulombe, P.A. 2003. Wound epithelialization: accelerating the pace of discovery. J. Invest. Dermatol. 121:219-230. http://dx.doi.org/10.1046/ j.1523-1747.2003.12387.x.
12. Demidova-Rice, T.N., L. Wolf, J. Deckenback, M.R. Hamblin, and I.M. Herman. 2012. Human platelet-rich plasma-and extracellular matrixderived peptides promote impaired cutaneous wound healing in vivo. PLoS ONE. 7:e32146. http://dx.doi.org/10.1371/journal.pone.0032146.
13. Esterbauer, H., R.J. Schaur, and H. Zollner. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128. http://dx.doi.org/10.1016/0891-5849 (91)90192-6.
14. Falanga, V., F. Grinnell, B. Gilchrest, Y.T. Maddox, and A. Moshell. 1994. Workshop on the pathogenesis of chronic wounds. J. Invest. Dermatol. 102:125-127. http://dx.doi.org/10.1111/1523-1747.ep12371745.
15. Fang, R.C., and R.D. Galiano. 2008. A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics. 2:1-12.
16. Fu, X., X. Li, B. Cheng, W. Chen, and Z. Sheng. 2005. Engineered growth factors and cutaneous wound healing: success and possible questions in the past 10 years. Wound Repair Regen. 13:122-130. http://dx.doi.org/10.1111/j.1067-1927.2005.130202.x.
17. Gillitzer, R., and M. Goebeler. 2001. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69:513-521.
18. Greenhalgh, D.G., K.H. Sprugel, M.J. Murray, and R. Ross. 1990. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am. J. Pathol. 136:1235-1246.
19. Group, S.C. 1989. Final Report on the Aspirin Component of the Ongoing Physicians' Health Study. N. Engl. J. Med. 321:129-135. http://dx.doi.org/ 10.1056/NEJM198907203210301.
20. Hamberg, M., J. Svensson, and B. Samuelsson. 1974. Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc. Natl. Acad. Sci. USA. 71:3824-3828. http://dx.doi.org/10.1073/pnas.71.10.3824.
21. Hennig, R., T. Osman, I. Esposito, N. Giese, S.M. Rao, X.Z. Ding, W.G. Tong, M.W. Büchler, T. Yokomizo, H. Friess, and T.E. Adrian. 2008. BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br. J. Cancer. 99:1064-1073. http://dx.doi.org/ 10.1038/sj.bjc.6604655.
22. Holvoet, S., C. Vincent, D. Schmitt, and M. Serres. 2003. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-α in human keratinocytes. Exp. Cell Res. 290:108-119. http://dx.doi.org/10.1016/S0014-4827(03)00293-3.
23. Iizuka, Y., T. Yokomizo, K. Terawaki, M. Komine, K. Tamaki, and T. Shimizu. 2005. Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J. Biol. Chem. 280:24816-24823. http:// dx.doi.org/10.1074/jbc.M413257200.
24. Iizuka, Y., T. Okuno, K. Saeki, H. Uozaki, S. Okada, T. Misaka, T. Sato, H. Toh, M. Fukayama, N. Takeda, et al. 2010. Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis. FASEB J. 24:4678-4690. http://dx.doi.org/10.1096/fj.10-165050.
25. Jeffcoate, W.J., and K.G. Harding. 2003. Diabetic foot ulcers. Lancet. 361:1545-1551. http://dx.doi.org/10.1016/S0140-6736(03)13169-8.
26. Kabashima, K., T. Murata, H. Tanaka, T. Matsuoka, D. Sakata, N. Yoshida, K. Katagiri, T. Kinashi, T. Tanaka, M. Miyasaka, et al. 2003. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4:694-701. http://dx.doi.org/10.1038/ni943.
27. Kamohara, M., J. Takasaki, M. Matsumoto, T. Saito, T. Ohishi, H. Ishii, and K. Furuichi. 2000. Molecular cloning and characterization of another leukotriene B4 receptor. J. Biol. Chem. 275:27000-27004.
28. Kaushal, M., N. Gopalan Kutty, and C. Mallikarjuna Rao. 2007. Wound healing activity of NOE-aspirin: a pre-clinical study. Nitric Oxide. 16:150-156. http://dx.doi.org/10.1016/j.niox.2006.07.004.
29. Kendall, A.C., and A. Nicolaou. 2013. Bioactive lipid mediators in skin inflammation and immunity. Prog. Lipid Res. 52:141-164. http://dx.doi.org/ 10.1016/j.plipres.2012.10.003.
30. Kita, Y., T. Takahashi, N. Uozumi, and T. Shimizu. 2005. A multiplex quantitation method for eicosanoids and platelet-activating factor using columnswitching reversed-phase liquid chromatography-tandem mass spectrometry. Anal. Biochem. 342:134-143. http://dx.doi.org/10.1016/j.ab.2005.03.048.
31. Kuprash, D.V., I.A. Udalova, R.L. Turetskaya, D. Kwiatkowski, N.R. Rice, and S.A. Nedospasov. 1999. Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J. Immunol. 162:4045-4052.
32. Kyriakides, T.R., D. Wulsin, E.A. Skokos, P. Fleckman, A. Pirrone, J.M. Shipley, R.M. Senior, and P. Bornstein. 2009. Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biol. 28:65-73. http://dx.doi.org/10.1016/j.matbio.2009.01.001.
33. Lichti, U., J. Anders, and S.H. Yuspa. 2008. Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat. Protoc. 3:799-810. http://dx.doi.org/10.1038/nprot.2008.50.
34. Luster, A.D., and A.M. Tager. 2004. T-cell trafficking in asthma: lipid mediators grease the way. Nat. Rev. Immunol. 4:711-724. http://dx.doi.org/10.1038/nri1438.
35. Martin, P. 1997. Wound healing-aiming for perfect skin regeneration. Science. 276:75-81. http://dx.doi.org/10.1126/science.276.5309.75.
36. Mathis, S., V.R. Jala, and B. Haribabu. 2007. Role of leukotriene B4 receptors in rheumatoid arthritis. Autoimmun. Rev. 7:12-17. http://dx.doi.org/10.1016/j.autrev.2007.03.005.
37. Matsunobu, T., T. Okuno, C. Yokoyama, and T. Yokomizo. 2013. Thromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand. J. Lipid Res. 54:2979-2987. http:// dx.doi.org/10.1194/jlr.M037754.
38. Mayser, P., H. Grimm, and F. Grimminger. 2002. n-3 fatty acids in psoriasis. Br. J. Nutr. 87:S77-S82. http://dx.doi.org/10.1079/BJN2001459.
39. McGrath, J.A., and S.M. Breathnach. 2004. Wound healing. In Rook's Textbook of Dermatology. T. Burns, S. Breathnach, N. Cox, and C. Griffiths, editors. Blackwell Science, Oxford. 11.11-11.25.
40. Miki, Y., K. Yamamoto, Y. Taketomi, H. Sato, K. Shimo, T. Kobayashi, Y. Ishikawa, T. Ishii, H. Nakanishi, K. Ikeda, et al. 2013. Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J. Exp. Med. 210:1217-1234. http://dx.doi.org/10.1084/jem.20121887.
41. Morris, T., M. Stables, A. Hobbs, P. de Souza, P. Colville-Nash, T. Warner, J. Newson, G. Bellingan, and D.W. Gilroy. 2009. Effects of lowdose aspirin on acute inflammatory responses in humans. J. Immunol. 183:2089-2096. http://dx.doi.org/10.4049/jimmunol.0900477.
42. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene. 108:193-199. http://dx.doi.org/10.1016/0378-1119(91)90434-D.
43. Norling, L.V., M. Spite, R. Yang, R.J. Flower, M. Perretti, and C.N. Serhan. 2011. Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. J. Immunol. 186:5543-5547. http://dx.doi.org/10.4049/jimmunol.1003865.
44. Okuno, T., Y. Iizuka, H. Okazaki, T. Yokomizo, R. Taguchi, and T. Shimizu. 2008. 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2. J. Exp. Med. 205:759-766. http://dx.doi.org/10.1084/jem.20072329.
45. Pollack, S.V. 1984. Systemic drugs and nutritional aspects of wound healing. Clin. Dermatol. 2:68-80. http://dx.doi.org/10.1016/0738-081X(84)90028-2.
46. Sasaki, F., T. Okuno, K. Saeki, L. Min, N. Onohara, H. Kato, T. Shimizu, and T. Yokomizo. 2012. A high-affinity monoclonal antibody against the FLAG tag useful for G-protein-coupled receptor study. Anal. Biochem. 425:157-165. http://dx.doi.org/10.1016/j.ab.2012.03.014.
47. Scott, K.A., C.H. Arnott, S.C. Robinson, R.J. Moore, R.G. Thompson, J.F. Marshall, and F.R. Balkwill. 2004. TNF-alpha regulates epithelial expression of MMP-9 and integrin αvβ6 during tumour promotion. A role for TNF-α in keratinocyte migration? Oncogene. 23:6954-6966. http://dx.doi.org/10.1038/sj.onc.1207915.
48. Serhan, C.N., S. Yacoubian, and R. Yang. 2008. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 3:279-312. http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.151409.
49. Seta, F., A.D. Chung, P.V. Turner, J.D. Mewburn, Y. Yu, and C.D. Funk. 2009. Renal and cardiovascular characterization of COX-2 knockdown mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296:R1751-R1760. http://dx.doi.org/10.1152/ajpregu.90985.2008.
50. Shao, W.H., A. Del Prete, C.B. Bock, and B. Haribabu. 2006. Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice. J. Immunol. 176:6254-6261. http://dx.doi.org/10.4049/jimmunol.176.10.6254.
51. Singer, A.J., and R.A. Clark. 1999. Cutaneous wound healing. N. Engl. J. Med. 341:738-746. http://dx.doi.org/10.1056/NEJM199909023411006.
52. Stojadinovic, O., H. Brem, C. Vouthounis, B. Lee, J. Fallon, M. Stallcup, A. Merchant, R.D. Galiano, and M. Tomic-Canic. 2005. Molecular pathogenesis of chronic wounds: the role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am. J. Pathol. 167:59-69. http://dx.doi.org/10.1016/S0002-9440(10)62953-7.
53. Sugimoto, Y., A. Yamasaki, E. Segi, K. Tsuboi, Y. Aze, T. Nishimura, H. Oida, N. Yoshida, T. Tanaka, M. Katsuyama, et al. 1997. Failure of parturition in mice lacking the prostaglandin F receptor. Science. 277:681-683. http://dx.doi.org/10.1126/science.277.5326.681.
54. Terawaki, K., T. Yokomizo, T. Nagase, A. Toda, M. Taniguchi, K. Hashizume, T. Yagi, and T. Shimizu. 2005. Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses. J. Immunol. 175:4217-4225. http://dx.doi.org/10.4049/jimmunol.175.7.4217.
55. Werner, S., and R. Grose. 2003. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83:835-870.
56. Woodward, D.F., R.L. Jones, and S. Narumiya. 2011. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol. Rev. 63:471-538. http://dx.doi.org/10.1124/pr.110.003517.
57. Yokomizo, T., T. Izumi, K. Chang, Y. Takuwa, and T. Shimizu. 1997. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature. 387:620-624. http://dx.doi.org/10.1038/42506.
58. Yokomizo, T., K. Kato, K. Terawaki, T. Izumi, and T. Shimizu. 2000a. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192:421-432. http://dx.doi.org/10.1084/jem.192.3.421.
59. 4 receptor. Cloning and intracellular signaling. Am. J. Respir. Crit. Care Med. 161:S51-S55. http://dx.doi.org/10.1164/ ajrccm.161.supplement_1.ltta-11.
60. Yokomizo, T., K. Kato, H. Hagiya, T. Izumi, and T. Shimizu. 2001. Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J. Biol. Chem. 276:12454-12459. http://dx.doi.org/ 10.1074/jbc.M011361200.
61. Yoo, M.H., H. Song, C.H. Woo, H. Kim, and J.H. Kim. 2004. Role of the BLT2, a leukotriene B4 receptor, in Ras transformation. Oncogene. 23:9259-9268.
62. Yu, Z., C. Schneider, W.E. Boeglin, and A.R. Brash. 2005. Mutations associated with a congenital form of ichthyosis (NCIE) inactivate the epidermal lipoxygenases 12R-LOX and eLOX3. Biochim. Biophys. Acta. 1686:238-247. http://dx.doi.org/10.1016/j.bbalip.2004.10.007.
63. Ziboh, V.A., C.C. Miller, and Y. Cho. 2000. Significance of lipoxygenasederived monohydroxy fatty acids in cutaneous biology. Prostaglandins Other Lipid Mediat. 63:3-13. http://dx.doi.org/10.1016/S0090-6980(00) 00093-9.